Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma

Chronobiology International

Volumn 33, Issue 2, 2016, Pages 210-219

  Hsu, Feng Ming ^a   Hou, Wei Hsien ^b   Huang, Chao Yuan ^c   Wang, Chia Chun ^a   Tsai, Chiao Ling ^a   Tsai, Yu Chieh ^a   Yu, Hong Jeng ^c   Pu, Yeong Shiau ^c   Cheng, Jason Chia Hsien ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Circadian rhythm; intensity modulated radiotherapy; prostate cancer; toxicity

Indexed keywords

ADENOCARCINOMA; AGED; CIRCADIAN RHYTHM; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CIRCADIAN RHYTHM; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84961211381     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420528.2015.1130049     Document Type: Article

References (43)

1. Ahowesso C, Li XM, Zampera S., et al. (2011). Sex and dosing-Time dependencies in irinotecan-induced circadian disruption. Chronobiol Int. 28: 458-70.
2. Al Mheid I, Corrigan F, Shirazi F., et al. (2014). Circadian variation in vascular function and regenerative capacity in healthy humans. J Am Heart Assoc. 15: e000845.
3. Allan DS, Morgan SC, Birch PE., et al. (2009). Mobilization of circulating vascular progenitors in cancer patients receiving external beam radiation in response to tissue injury. Int J Radiat Oncol Biol Phys. 75: 220-4.
4. Allebrandt KV, Teder-Laving M, Kantermann T., et al. (2014). Chronotype and sleep duration: The influence of season of assessment. Chronobiol Int. 31: 731-40.
5. Badiyan SN, Ferraro DJ, Yaddanapudi S., et al. (2013). Impact of time of day on outcomes after stereotactic radiosurgery for non-small cell lung cancer brain metastases. Cancer. 119: 3563-9.
6. Bartsch C, Bartsch H, Bichler KH, Fluchter SH. (1998). Prostate cancer and tumor stage- dependent circadian neuroendocrine disturbances. The Aging Male. 1: 188-99.
7. Bjarnason GA, Mackenzie RG, Nabid A., et al. (2009). Comparison of toxicity associated with early morning versus late afternoon RT in patients with head-And-neck cancer: A prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3). Int J Radiat Oncol Biol Phys. 73: 166-72.
8. Brown SA, Schmitt K, Eckert A. (2011). Aging and circadian disruption: Causes and effects Vol 3. Albany, NY: Aging. pp. 813-7.
9. Buchi KN, Moore JG, Hrushesky WJ., et al. (1991). Circadian rhythm of cellular proliferation in the human rectal mucosa. Gastroenterology. 101: 410-5.
10. Butler MP, Karatsoreos IN, LeSauter J, Silver R. (2012). Dose-dependent effects of androgens on the circadian timing system and its response to light. Endocrinology. 153: 2344-52.
11. Cao Q, Gery S, Dashti A., et al. (2009). A role for the clock gene per1 in prostate cancer. Cancer Res. 69: 7619-25.
12. Clayton F, Tessnow KA, Fang JC., et al. (2002). Circadian variation of topoisomerase II-Alpha in human rectal crypt epithelium: Implications for reduction of toxicity of chemotherapy. Mod Pathol. 15: 1191-6.
13. Flynn-Evans EE, Mucci L, Stevens RG, Lockley SW. (2013). Shiftwork and prostate-specific antigen in the National Health and Nutrition Examination Survey. J Natl Cancer Inst. 105: 1292-7.
14. Giacchetti S, Dugué PA, Innominato PF., et al. (2012). Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: A meta-Analysis. Ann Oncol. 23: 3110-6.
15. Goyal M, Shukla P, Gupta D, et al. (2009). Oral mucositis in morning vs. evening irradiated patients: A randomised prospective study. Int J Radiat Biol. 85: 504-9.
16. Haridas S, Kumar M, Manda K. (2012). Chronic melatonin administration mitigates behavioral dysfunction induced by γ-irradiation. Horm Behav. 62: 621-7.
17. Haus E. (2002). Chronobiology of the mammalian response to ionizing radiation. Potential applications in oncology. Chronobiol Int. 19: 77-100.
18. Ho DE, Imai K, King G, Stuart EA. (2007). Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Political Analysis. 15: 199-236.
19. Innominato PF, Roche VP, Palesh OG., et al. (2014). The circadian timing system in clinical oncology. Ann Med. 46: 191-207.
20. Jagota A, de la Iglesia HO, Schwartz WJ. (2000). Morning and evening circadian oscillations in the suprachiasmatic nucleus in vitro. Nat Neurosci. 3: 372-6.
21. Jung-Hynes B, Huang W, Reiter RJ, Ahmad N. (2010). Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells. J Pineal Res. 49: 60-8.
22. Kuban DA, Tucker SL, Dong L., et al. (2008). Long-Term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys. 70: 67-74.
23. Lee MO, Song SH, Jung S., et al. (2012). Effect of ionizing radiation induced damage of endothelial progenitor cells in vascular regeneration. Arterioscler Thromb Vasc Biol. 32: 343-52.
24. Levi F, Zidani R, Misset JL. (1997). Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Int Organiz Cancer Chronotherapy Lancet. 350: 681-6.
25. Li XM, Mohammad-Djafari A, Dumitru M., et al. (2013). A circadian clock transcription model for the personalization of cancer chronotherapy. Cancer Res. 73: 7176-88.
26. Model Z, Butler MP, LeSauter J, Silver R. (2015). Suprachiasmatic nucleus as the site of androgen action on circadian rhythms. Horm Behav. 73: 1-7.
27. Mormont MC, Waterhouse J, Bleuzen P, et al. (2000). Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res. 6: 3038-45.
28. Noh JM, Choi DH, Park H., et al. (2014). Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection. J Radiat Res. 132: 618-23.
29. Palombo P, Moreno-Villanueva M, Mangerich A. (2015). Day and night variations in the repair of ionizing-radiation-induced DNA damage in mouse splenocytes. DNA Repair (Amst). 28: 37-47.
30. Paris F, Fuks Z, Kang A, et al. (2001). Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science. 293: 293-7.
31. Peeters ST, Heemsbergen WD, Koper PC., et al. (2006). Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol. 24: 1990-6.
32. Pittendrigh CS. (1993). Temporal organization: Reflections of a Darwinian clock-watcher. Annu Rev Physiol. 55: 16-54.
33. Rahn DA 3rd, Ray DK, Schlesinger DJ., et al. (2011). Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: Is there a difference in outcome between morning and afternoon treatment? Cancer. 117: 414-20.
34. Reppert SM, Weaver DR. (2002). Coordination of circadian timing in mammals. Nature. 418: 935-41.
35. Roach M 3rd, Waldman F, Pollack A. (2009). Predictive models in external beam radiotherapy for clinically localized prostate cancer. Cancer. 115: 3112-20.
36. Roenneberg T, Kuehnle T, Juda M., et al. (2007). Epidemiology of the human circadian clock. Sleep Med Rev. 11: 429-38.
37. Shukla P, Gupta D, Bisht SS, et al. (2010). Circadian variation in radiation-induced intestinal mucositis in patients with cervical carcinoma. Cancer. 116: 2031-5.
38. Sothern RB, Smaaland R, Moore JG. (1995). Circannual rhythm in DNA synthesis (S-phase) in healthy human bone marrow and rectal mucosa. FASEB J. 9: 397-403.
39. Watson T1, Shantsila E, Karthikeyan VJ., et al. (2010). The effects of exercise stress testing, diurnal variation andtemporal decline on circulating progenitor cells. Thromb Haemost. 103: 419-25.
40. Zhanfeng N, Yanhui L, Zhou F., et al. (2015). Circadian genes Per1 and Per2 increase radiosensitivity of glioma in vivo. Oncotarget. 6: 9951-8.
41. Zhang Y, Chen X, Ren P., et al. (2013). Synergistic effect of combination topotecan and chronomodulated radiation therapy on xenografted human nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 87: 356-62.
42. Zhu Y, Stevens RG, Hoffman AE., et al. (2009). Testing the circadian gene hypothesis in prostate cancer: A population-based case-control study. Cancer Res. 69: 9315-22.
43. Zietman AL, Bae K, Slater JD., et al. (2010). Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-Term results from proton radiation oncology group/american college of radiology 95-09. J Clin Oncol. 28: 1106-11.